The United States Food and Drug Administration (USFDA) approves Zydus Lifescience for Empagliflozin and Metformin Hydrochloride Tablets in 5 mg/500 mg, 5 mg/1000 mg, 12.5 mg/500 mg, and 12.5 mg/1000 mg.

• KPI Green Energy Signs $4-Billion Botswana MoU; Shares Surge 3.25%
• Sun Pharmaceutical Shares Slump 3% as USFDA Highlights Facility 
• Mahindra Lifespace Launches Rs 1,900-Crore Bengaluru Project; Shares Fall 1.25%
• Stocks Under F&O Ban: Bandhan Bank
• Overnight Stock Market Movements: Key Developments 

These tablets are used for proper diet and exercise, which improves glycemic control in adults with two types of diabetes mellitus.

Also, they are used to lower the risk of cardiovascular disease. In India, only Ahmedabad will be manufactured at the formulation facility at SEZ.